Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Rooney

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 31, 2023
A Practical Guide to 16S rRNA Microbiome Analysis in Musculoskeletal DisordersC M Rooney, S Mitra
Virology|December 1, 1992
The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responsesJ P Stewart, C M Rooney
British Journal of Rheumatology|January 1, 1996
Young adults with arthritis: meeting their transitional needsM A Chamberlain, C M Rooney
Immunology|January 1, 1984
NK cells can recognize asialylated autologous lymphocytes and ABO-mismatched lymphocytesC M Rooney, A J Munro
Immunological Reviews|June 1, 1997
Adoptive cellular immunotherapy for EBV lymphoproliferative diseaseH E Heslop, C M Rooney
Leukemia & Lymphoma|May 9, 2001
The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipientsB Savoldo, H E Heslop, C M Rooney
Bone Marrow Transplantation|November 6, 2007
Adoptive cellular immunotherapy for viral diseasesY Fujita, C M Rooney, H E Heslop
The Journal of Infectious Diseases|April 10, 2021
Protecting the MicrobiotaC M Rooney, S Ahmed, M H Wilcox
Current Opinion in Oncology|April 3, 1999
Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantationL K Aguilar, C M Rooney, H E Heslop
Molecular Medicine Today|January 1, 1997
Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunityC M Rooney, C A Smith, H E Heslop
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|May 31, 2023
A Practical Guide to 16S rRNA Microbiome Analysis in Musculoskeletal DisordersC M Rooney, S Mitra
Virology|December 1, 1992
The interleukin-10 homolog encoded by Epstein-Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responsesJ P Stewart, C M Rooney
British Journal of Rheumatology|January 1, 1996
Young adults with arthritis: meeting their transitional needsM A Chamberlain, C M Rooney
Immunology|January 1, 1984
NK cells can recognize asialylated autologous lymphocytes and ABO-mismatched lymphocytesC M Rooney, A J Munro
Immunological Reviews|June 1, 1997
Adoptive cellular immunotherapy for EBV lymphoproliferative diseaseH E Heslop, C M Rooney
Leukemia & Lymphoma|May 9, 2001
The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipientsB Savoldo, H E Heslop, C M Rooney
Bone Marrow Transplantation|November 6, 2007
Adoptive cellular immunotherapy for viral diseasesY Fujita, C M Rooney, H E Heslop
The Journal of Infectious Diseases|April 10, 2021
Protecting the MicrobiotaC M Rooney, S Ahmed, M H Wilcox
Current Opinion in Oncology|April 3, 1999
Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantationL K Aguilar, C M Rooney, H E Heslop
Molecular Medicine Today|January 1, 1997
Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunityC M Rooney, C A Smith, H E Heslop
Pageof 8